- $3.10bn
- $2.53bn
- $4.95bn
- 85
- 91
- 68
- 95
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,623 | 2,881 | 3,318 | 4,982 | 4,947 |
Cost of Revenue | |||||
Gross Profit | 1,087 | 356 | 765 | 1,691 | 1,562 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4,562 | 4,609 | 2,853 | 3,658 | 3,881 |
Operating Profit | 61.5 | -1,728 | 465 | 1,324 | 1,066 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -142 | -1,852 | 370 | 1,279 | 1,125 |
Provision for Income Taxes | |||||
Net Income After Taxes | -188 | -1,860 | 347 | 1,317 | 816 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -211 | -1,870 | 360 | 1,297 | 760 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -211 | -1,870 | 360 | 1,297 | 760 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.663 | -8.8 | 2.53 | 8.42 | 4.92 |
Dividends per Share | |||||
Special Dividends per Share |